These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 21134755
1. Identification of novel ASK1 inhibitors using virtual screening. Okamoto M, Saito N, Kojima H, Okabe T, Takeda K, Ichijo H, Furuya T, Nagano T. Bioorg Med Chem; 2011 Jan 01; 19(1):486-9. PubMed ID: 21134755 [Abstract] [Full Text] [Related]
2. Virtual screening and further development of novel ALK inhibitors. Okamoto M, Kojima H, Saito N, Okabe T, Masuda Y, Furuya T, Nagano T. Bioorg Med Chem; 2011 May 15; 19(10):3086-95. PubMed ID: 21515061 [Abstract] [Full Text] [Related]
3. Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors. Terao Y, Suzuki H, Yoshikawa M, Yashiro H, Takekawa S, Fujitani Y, Okada K, Inoue Y, Yamamoto Y, Nakagawa H, Yao S, Kawamoto T, Uchikawa O. Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7326-9. PubMed ID: 23147077 [Abstract] [Full Text] [Related]
4. Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1). Volynets GP, Chekanov MO, Synyugin AR, Golub AG, Kukharenko OP, Bdzhola VG, Yarmoluk SM. J Med Chem; 2011 Apr 28; 54(8):2680-6. PubMed ID: 21449566 [Abstract] [Full Text] [Related]
9. Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Gibson TS, Johnson B, Fanjul A, Halkowycz P, Dougan DR, Cole D, Swann S. Bioorg Med Chem Lett; 2017 Apr 15; 27(8):1709-1713. PubMed ID: 28291695 [Abstract] [Full Text] [Related]
10. Discovery and development of ASK1 inhibitors. Brys R, Gibson K, Poljak T, Van Der Plas S, Amantini D. Prog Med Chem; 2020 Apr 15; 59():101-179. PubMed ID: 32362327 [Abstract] [Full Text] [Related]
11. Evaluation of WO2012003387, Gilead's ASK1 inhibitors. Norman P. Expert Opin Ther Pat; 2012 Apr 15; 22(4):455-9. PubMed ID: 22439661 [Abstract] [Full Text] [Related]
15. Apoptosis signal-regulating kinase 1 as a therapeutic target. Kawarazaki Y, Ichijo H, Naguro I. Expert Opin Ther Targets; 2014 Jun 15; 18(6):651-64. PubMed ID: 24660755 [Abstract] [Full Text] [Related]
16. Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1. Alavi AS, Acevedo L, Min W, Cheresh DA. Cancer Res; 2007 Mar 15; 67(6):2766-72. PubMed ID: 17363598 [Abstract] [Full Text] [Related]
17. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. Cheeseright TJ, Holm M, Lehmann F, Luik S, Göttert M, Melville JL, Laufer S. J Med Chem; 2009 Jul 23; 52(14):4200-9. PubMed ID: 19489590 [Abstract] [Full Text] [Related]
19. Therapeutic targets in the ASK1-dependent stress signaling pathways. Hayakawa R, Hayakawa T, Takeda K, Ichijo H. Proc Jpn Acad Ser B Phys Biol Sci; 2012 Jul 23; 88(8):434-53. PubMed ID: 23060232 [Abstract] [Full Text] [Related]
20. Apoptosis signal-regulating kinase 1 is crucial for oxidative stress-induced but not for osmotic stress-induced hepatocyte cell death. Taki K, Shimozono R, Kusano H, Suzuki N, Shinjo K, Eda H. Life Sci; 2008 Dec 19; 83(25-26):859-64. PubMed ID: 18983857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]